Cargando…
Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one?
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Fondazione Ferrata Storti
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556626/ https://www.ncbi.nlm.nih.gov/pubmed/33054041 http://dx.doi.org/10.3324/haematol.2020.256602 |
_version_ | 1783594260215365632 |
---|---|
author | Silver, Richard T. |
author_facet | Silver, Richard T. |
author_sort | Silver, Richard T. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7556626 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Fondazione Ferrata Storti |
record_format | MEDLINE/PubMed |
spelling | pubmed-75566262020-10-15 Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? Silver, Richard T. Haematologica Editorials Fondazione Ferrata Storti 2020-09-01 /pmc/articles/PMC7556626/ /pubmed/33054041 http://dx.doi.org/10.3324/haematol.2020.256602 Text en Copyright© 2020 Ferrata Storti Foundation http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
spellingShingle | Editorials Silver, Richard T. Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? |
title | Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? |
title_full | Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? |
title_fullStr | Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? |
title_full_unstemmed | Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? |
title_short | Combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? |
title_sort | combination therapy with interferon and ruxolitinib for polycythemia vera and myelofibrosis: are two drugs better than one? |
topic | Editorials |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556626/ https://www.ncbi.nlm.nih.gov/pubmed/33054041 http://dx.doi.org/10.3324/haematol.2020.256602 |
work_keys_str_mv | AT silverrichardt combinationtherapywithinterferonandruxolitinibforpolycythemiaveraandmyelofibrosisaretwodrugsbetterthanone |